Johnson & Johnson to Halt Sales of Trans-Vaginal Mesh Implants
GREENSBORO, N.C. – June 5, 2012 – Johnson & Johnson intends to stop selling four vaginal mesh implants after being sued by more than 600 women who say the products caused internal injuries. “This move highlights the serious health issues with trans-vaginal mesh products,” said Brian Kinsley, Crumley Roberts’ Practice Group Leader for Product Liability.
According to Bloomberg News, the company has asked the FDA for 120 days to end sales so it can “notify its customers and provide those hospitals and surgeons with sufficient time to select alternative treatment options for their patients,” the J&J subsidiary said in its letter. “Ethicon will also discontinue or revise, as appropriate, all marketing materials during this time.” This past January, Johnson & Johnsonand 30 other makers of vaginal mesh implants were ordered by the FDA to study organ damage and other health complications blamed on the products, which are used to treat incontinence and shore up weakened pelvic muscles.
The FDA reports that significant complications resulting from trans-vaginal mesh patches are not rare and commonly involve issues such as: erosion of vaginal tissue, infection, bleeding, pain, urinary problems, and organ perforation.
Founded in 1989, Crumley Roberts, LLP, represents individuals with personal injury, workers' compensation and Social Security disability claims. The firm operates from 14 offices in North Carolina and South Carolina. If you, or someone you care about, has a trans-vaginal mesh used to correct pelvic organ prolapse and suffered any of the above symptoms, our law firm may be able to help.Free Initial Consultation